Researcher Profiles

All Members

Search by Name (ALL MEMBERS)

Last Name: and/or First Name:

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Show All

Leonid Kagan, PhD
Associate II Member,
Cancer Pharmacology Program

Yibin Kang, PhD
Full Member,
Cancer Metabolism and Growth Program

Howard L. Kaufman, MD, FACS
Full Member,
Clinical Investigations and Precision Therapeutics Program

Neerja Kaushik-Basu, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

Thomas J. Kearney, MD, FACS
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

John E. Kerrigan, PhD
Associate II Member,
Cancer Pharmacology Program

Atif J. Khan, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Megerditch (Mike) Kiledjian, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Isaac Yi Kim, MD, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Leonard H. Kim, MS, AMusD, DABR
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Sung Kim, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

S. David Kimball, PhD
Associate II Member,
Cancer Pharmacology Program

Terri Goss Kinzy, PhD
Associate I Member,
Program: non-aligned

Howard M. Kipen, MD, MPH
Associate II Member,
Cancer Prevention and Control Program

Laurie J. Kirstein, MD, FACS
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Spencer A. Knapp, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Joachim B. Kohn, PhD
Full Member,
Cancer Pharmacology Program

A.-N. Tony Kong, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Vadim Koshenkov, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Sunita G. Kramer, PhD
Full Member,
Cancer Metabolism and Growth Program